pharma news, views and analysis

in News
Sanofi/Regeneron’s Dupixent could be first biologic approved for nasal polyps
October 16, 2018 Share
X
Sanofi/Regeneron’s Dupixent could be first biologic approved for nasal polyps
https://pharmaphorum.com/news/sanofi-regenerons-dupixent-could-be-first-biologic-approved-for-nasal-polyps/
in News
Merck KGaA’s BTK drug reduces lesions in relapsing MS patients
October 15, 2018 Share
X
Merck KGaA’s BTK drug reduces lesions in relapsing MS patients
https://pharmaphorum.com/news/merck-kgaas-btk-drug-reduces-lesions-in-relapsing-ms-patients/

Latest News

Ionis and Roche to develop RNAi AMD drug in $760m deal

Ionis and Roche have struck a deal worth up to $760 million (£575 million) to develop a drug

Ionis and Roche to develop RNAi AMD drug in $760m deal

https://pharmaphorum.com/news/ionis-and-roche-to-develop-rnai-amd-drug-in-760m-deal/

Number of UK clinical trials in decline since Brexit vote

Ongoing uncertainty and concern about Brexit has already cut the number of clinical trials carried out in the

Number of UK clinical trials in decline since Brexit vote

https://pharmaphorum.com/news/number-of-uk-clinical-trials-in-decline-since-brexit-vote/

FDA gives go-ahead for CRISPR-based sickle cell disease trial

Development of a stem cell therapy for sickle cell disease from Vertex and development partner CRISPR therapeutics can

FDA gives go-ahead for CRISPR-based sickle cell disease trial

https://pharmaphorum.com/news/fda-gives-go-ahead-for-crispr-based-sickle-cell-disease-trial/

See all

Views & Analysis

Calliditas pushing on with kidney disease drug after IPO success

Calliditas Therapeutics has just pulled off the largest biotech IPO in Europe this year and is using it

Calliditas pushing on with kidney disease drug after IPO success

https://pharmaphorum.com/r-d/views-analysis-r-d/calliditas-pushing-kidney-disease-drug-ipo-success/

Boosting clinical trial productivity to prove Eroom wrong

According to Eroom’s law, drug discovery becomes slower and costlier over time. And the data are, at least

Boosting clinical trial productivity to prove Eroom wrong

https://pharmaphorum.com/r-d/boosting-clinical-trial-productivity-to-prove-eroom-wrong/

The art of storytelling in clinical data communication − what we can learn from Batman and the Joker?

What can we learn from Batman and the Joker, the greatest hero/villain pairing of all time? Their co-dependent

The art of storytelling in clinical data communication − what we can learn from Batman and the Joker?

https://pharmaphorum.com/r-d/views-analysis-r-d/art-storytelling-clinical-data-communication/

See all

Debates & Insights

Marketing science – brand innovation for pharma

Combining fields such as economics, statistics and operations research, marketing science has for some time operated under-the-radar as

Marketing science – brand innovation for pharma

https://pharmaphorum.com/debates-insight-sales-marketing/marketing-science-brand-innovation-for-pharma/

Digital health: how can technology be used to engage hard-to-reach patients and assist with patient monitoring?

Helping someone live with a condition as complex as MS can be fraught with challenges. MS professionals are

Digital health: how can technology be used to engage hard-to-reach patients and assist with patient monitoring?

https://pharmaphorum.com/debates-insight-digital/digital-health-can-technology-used-engage-hard-reach-patients-assist-patient-monitoring/

New report: Are clinical trials under threat from ‘system overload’?

The 2017 Unified Clinical Operations Survey Report Nearly all (99%) of clinical operations professionals who responded to the

New report: Are clinical trials under threat from ‘system overload’?

https://pharmaphorum.com/debates-insight-market-access/new-report-clinical-trials-threat-system-overload/

See all

Partner Content

SMi’s 10th Annual RNA Therapeutics Returns this February 2019

RNA Therapeutics 2019

SMi’s 10th Annual RNA Therapeutics Returns this February 2019

https://pharmaphorum.com/events/smis-10th-annual-rna-therapeutics-returns-this-february-2019/

The 10th Annual RNA Therapeutics Returns to London this Feb!

RNA Therapeutics

The 10th Annual RNA Therapeutics Returns to London this Feb!

https://pharmaphorum.com/partner-content/the-10th-annual-rna-therapeutics-returns-to-london-this-feb/

A Run Down of Keynote Sessions for Cell & Gene Therapy 2018

Cell and Gene Therapy

A Run Down of Keynote Sessions for Cell & Gene Therapy 2018

https://pharmaphorum.com/partner-content/a-run-down-of-keynote-sessions-for-cell-gene-therapy-2018/

See all

Search

Advanced Search

Trending